PMID: 11902501Mar 21, 2002Paper

Myeloprotection with drug-resistance genes

The Lancet Oncology
Debabrata Banerjee, Joseph R Bertino

Abstract

One of the many applications of gene transfer for cancer gene therapy is the transfer of drug-resistance genes into bone-marrow stem cells for myeloprotection. Protection of the hosts' bone marrow should allow for dose escalation that may be useful for eradicating minimal residual disease in a post-transplant situation. A number of drug resistance genes, whose products include mutant forms of enzymes that confer resistance to chemotherapeutic drugs, are discussed. Advances in hematopoietic stem cell isolation and ex vivo manipulation has kept pace with improvements in retroviral vector technology to make hematopoietic stem cell transduction a distinct reality. Clinical trials, which have established that the approach is safe, are now being designed to address more therapeutically relevant issues.

References

Aug 1, 1990·Journal of the National Cancer Institute·J R Bertino
Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·I RivièreR C Mulligan
Jul 1, 1994·Stem Cells·D BanerjeeJ R Bertino
Jan 1, 1993·Critical Reviews in Biochemistry and Molecular Biology·V Daniel
Aug 1, 1996·Nature Medicine·V Kumar, E Sercarz
Aug 1, 1996·The Journal of Experimental Medicine·D BoczkowskiE Gilboa
Jan 1, 1997·Stem Cells·T LichtI Pastan
Sep 26, 1997·Nature·I M Verma, N Somia
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C HesdorfferK Antman
Sep 25, 1998·The Journal of Biological Chemistry·D M Landis, L A Loeb
Oct 15, 1998·Nature Medicine·J A AllayB P Sorrentino
Mar 12, 1999·Annual Review of Medicine·J M Timmerman, R Levy
Jul 22, 1999·The New England Journal of Medicine·R A Seder, S Gurunathan
Sep 25, 1999·Journal of Cellular Physiology·U GalderisiA Giordano
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C HudisL Norton
Feb 19, 2000·Gene Therapy·R G VileN R Lemoine
Apr 20, 2000·Journal of the National Cancer Institute·C T YangD M Jablons
Apr 28, 2000·Science·M Cavazzana-CalvoA Fischer
May 5, 2000·The Oncologist·A RibasJ S Economou
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·P L Zeitlin
Mar 20, 2001·Nature Reviews. Genetics·N Somia, I M Verma

❮ Previous
Next ❯

Citations

Jul 23, 2005·Cancer Gene Therapy·Tulin Budak-AlpdoganJoseph R Bertino
Mar 11, 2009·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jordan P Volpato, Joelle N Pelletier
Apr 12, 2008·The International Journal of Biochemistry & Cell Biology·Aldo A Arvizu-FloresRogerio R Sotelo-Mundo
Oct 26, 2005·Nuclear Medicine and Biology·Inna Serganova, Ronald Blasberg
Aug 13, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kalevi J Pulkkanen, Seppo Yla-Herttuala
Nov 8, 2002·British Medical Bulletin·Daniel H PalmerDavid J Kerr
Aug 15, 2019·Seminars in Cancer Biology·Stefania NobiliEnrico Mini
Jul 11, 2003·The Veterinary Clinics of North America. Small Animal Practice·Philip J Bergman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.